GLIBLY-MF

Composition:-

Glibenclamide IP 5 mg.

Metformin HCL IP 500 mg.

Box pack:-

10 x 10 Tablets

An effective blood glucose control in uncontrolled Type-II Diabetes

GLIBENCLAMIDE

• Stimulates the secretion of insulin by deta cells
• Shows greatest antihyperglycaemic effects

METFORMIN

• Improves insulin sensitivity & secretion with beneficial effect on lipid levels
• Increases glucose utilization in liver & adipose tissues

Features:

• Improves insulin secretion & sensitivity
• Restores the early peak of insulin secretion
• Ensures glycaemic control throughout 24 hours without hypoglycemia
• Scavenges free radicals
• Offers unmatched macro and microvascular benefits.

In : • Moderate to severe NIDDM • NIDDM with vascular complications

For superior glycemic control